Celyad Oncology SA Logo

Celyad Oncology SA

Clinical-stage biotech developing CAR T therapies for solid and blood cancers.

CYAD | BR

Overview

Corporate Details

ISIN(s):
BE0974260896 (+2 more)
LEI:
549300ORR0M8XF56OI64
Country:
Belgium
Address:
RUE ANDRE DUMONT 9, 1435 MONT-SAINT-GUIBERT
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Celyad Oncology SA is a clinical-stage biotechnology company that specializes in the discovery and development of Chimeric Antigen Receptor T-cell (CAR T) therapies for cancer treatment. The company focuses on pioneering advanced technologies to create a pipeline of both allogeneic (off-the-shelf) and autologous (patient-derived) CAR T-cell candidates. Celyad's differentiated strategy aims to broaden the range of treatable cancer indications, including hematological malignancies and solid tumors, while addressing the primary limitations of existing CAR T-cell therapies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-04 00:00
Declaration of Voting Results & Voting Rights Announcements
20250904_PR_Double-voting-rights.ENG_Website.pdf
English 154.5 KB
2025-09-04 00:00
Declaration of Voting Results & Voting Rights Announcements
20250904_PR_Double-droit-de-vote.FR_Website.pdf
French 91.2 KB
2025-08-26 08:30
Regulatory News Service
20250826_PR_R&D discontinuation ENG.FINAL.clean.pdf
English 176.9 KB
2025-08-26 08:30
Regulatory News Service
20250826_PR_Arret R&D FR.FINAL.pdf
French 162.6 KB
2025-08-13 00:00
Major Shareholding Notification
20250913_PR_Fortress Transparency Notification ENG.Final.pdf
English 238.9 KB
2025-08-13 00:00
Major Shareholding Notification
20250913_PR_Fortress Transparency Notification FR.Final.pdf
French 224.1 KB
2025-08-07 00:00
Declaration of Voting Results & Voting Rights Announcements
20250807 PR_Total Number of Voting Rights and Shares_ENG.3.pdf
English 106.6 KB
2025-08-07 00:00
Declaration of Voting Results & Voting Rights Announcements
20250807 PR_Total Number of Voting Rights and Shares_FR.2.pdf
French 110.9 KB
2025-08-07 00:00
Declaration of Voting Results & Voting Rights Announcements
20250807 PR_Total Number of Voting Rights and Shares_ENG.3.pdf
English 106.6 KB
2025-08-07 00:00
Declaration of Voting Results & Voting Rights Announcements
20250807 PR_Total Number of Voting Rights and Shares_FR.2.pdf
French 110.9 KB
2025-08-05 00:00
Post-Annual General Meeting Information
PV Notaire.5août2025.signed.pdf
French 334.3 KB
2025-08-05 00:00
Audit Report / Information
CELYAD_ Rapport de Commissaire - Augm de K 1 MEUR_VDEF_SIGNED_280725.pdf
French 150.8 KB
2025-08-05 00:00
Share Issue/Capital Change
FR_Celyad_Rapport Special du CA_PIPE2025_23juillet2025.FE.pdf
French 2.6 MB
2025-08-05 00:00
Share Issue/Capital Change
20250724_CYAD-PR-PIPE-ENG.2.pdf
English 113.4 KB
2025-08-05 00:00
Share Issue/Capital Change
20250724_CYAD-PR-PIPE-FR.2.pdf
French 86.4 KB

Automate Your Workflow. Get a real-time feed of all Celyad Oncology SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Celyad Oncology SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-28 Kane Matthew Board Other 1,035,714 279,642.78 EUR
2024-11-26 Piscitelli Dominic Board Other 10,000 2,700.00 EUR
2024-11-25 Iserentant Hannes Executive member Other 30,000 8,100.00 EUR
2024-11-22 Phan An Executive member Other 30,000 8,100.00 EUR
2024-11-06 Goblet Serge Board Other 10,000 2,700.00 EUR
2024-11-05 Udier Blagovic Marina Board Other 10,000 2,700.00 EUR

Peer Companies

Company Country Ticker View
Bestone.Com Co.,Ltd Logo
An online travel agency specializing in domestic and overseas cruise tours and tickets.
Japan 6577
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel BONS
BRAIN Biotech AG Logo
Develops custom enzymes and microbes for the food, nutrition, and chemical industries.
Germany BNN
Branding Technology Inc. Logo
Drives digital transformation for SMEs with data-driven digital marketing and brand development.
Japan 7067
BrightBid Group Logo
AI SaaS platform automating paid search & shopping ads for businesses to maximize ROI.
Sweden BRIGHT

Talk to a Data Expert

Have a question? We'll get back to you promptly.